0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
"United States Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 - 2022 "
Published Date: February 2019
|
Report Code: DPIR-Medi-36
Home | Category |Health |Health Conditions |Endocrine Conditions
United States Insulin Pen Market 2017 2022

"United States Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 - 2022 "

Code: DPIR-Medi-36
Report
February 2019
60 Pages
DPI Research
Region: North America, South America,
Description
Table of Content

United States Insulin Pen Market is expected to reach more than US$2.5 Billion by 2022.

Market growth can be attributed to factors such as diabetes patient population, user–friendly design, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs and technological advancements in the field of insulin pen devices. However, low patient awareness, lack of device education and training among physicians and perception of the higher cost is expected to hamper growth of the market during forecast period.

“United States Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022” provides a deep and thorough evaluation of the United States Insulin Pen Market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into insulin pen users with more focused–on reusable and prefilled insulin pen users. Market outlook in value terms has been analysed based on current and potential trends and the market is estimated from 2017 to 2022. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pen Market.

The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• United States Insulin Users (2011 – 2022)
• United States Insulin Pen Users (2011 – 2022)
• United States Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
• United States Prefilled (Disposable) Insulin Pen Users (2011 – 2022)
• United States Insulin Pen Market (2011 – 2022)
• United States Reusable (Cartridge) Insulin Pen Market (2011 – 2022)
• United States Prefilled (Disposable) Insulin Pen Market (2011 – 2022)
• United States Insulin Pen Market: Reimbursement & Regulation System
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States Insulin Pen Market

Key Companies Covered in the Report are as follows:

• Novo Nordisk
• Eli Lilly
• Sanofi
• Owen Mumford

Table of Contents

1. Executive Summary

2. United States Diabetes Population & Insulin Users Analysis (2011 – 2022)
2.1 Overall Diabetes Population
2.2 Insulin Users

3. United States – Insulin Pen Users Trend & Analysis (2011 – 2022)
3.1 Insulin Pen Users & Forecast
3.1.1 Reusable (Cartridge) Insulin Pen Users
3.1.2 Prefilled (Disposable) Insulin Pen Users
3.2 Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Users Share

4. United States – Insulin Pen Market Trend & Analysis (2011 – 2022)
4.1 Insulin Pen Market & Forecast
4.1.1 Reusable (Cartridge) Insulin Pen Market
4.1.2 Prefilled (Disposable) Insulin Pen Market
4.2 Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Market Share

5. Key Drivers and Inhibitors of the United States Insulin Pen Market
5.1 Market Drivers
5.2 Inhibitors

6. United States Insulin Pen Market: Reimbursement & Regulation System
6.1 Reimbursement System
6.2 Regulation System

7. Key Companies Analysis
7.1 Novo Nordisk
7.1.1 Business Overview
7.1.2 Insulin Pen – Products Portfolio
7.1.3 Insulin Pen – Latest Development & Trends
7.2 Eli Lilly
7.2.1 Business Overview
7.2.2 Insulin Pen – Products Portfolio
7.2.3 Insulin Pen – Latest Development & Trends
7.3 Sanofi
7.3.1 Business Overview
7.3.2 Insulin Pen – Products Portfolio
7.4 Owen Mumford
7.4.1 Business Overview
7.4.2 Insulin Pen – Products Portfolio

United States Insulin Pen Market is expected to reach more than US$2.5 Billion by 2022.

Market growth can be attributed to factors such as diabetes patient population, user–friendly design, help avoid over/under–dosing of insulin, rising market demand for human insulin analogs and technological advancements in the field of insulin pen devices. However, low patient awareness, lack of device education and training among physicians and perception of the higher cost is expected to hamper growth of the market during forecast period.

“United States Insulin Pen Market Size, Share, Opportunity, Analysis, Growth Potential & Demand Forecast 2017 – 2022” provides a deep and thorough evaluation of the United States Insulin Pen Market. The report provides an in–depth analysis of overall diabetes population and insulin users. It provides essential insights into insulin pen users with more focused–on reusable and prefilled insulin pen users. Market outlook in value terms has been analysed based on current and potential trends and the market is estimated from 2017 to 2022. It also covers reimbursement pattern and offers a clear view of the regulatory landscape. The report also explores detailed description of growth drivers and inhibitors of the United States Insulin Pen Market.

The report concludes with the profiles of major players in the Insulin Pen Market such as Novo Nordisk, Eli Lilly, Sanofi, Owen Mumford. The major market players are evaluated on various parameters such as company overview, product outlook and latest development and trends of the Insulin Pen Market.

Key Topics Covered in the Report

• United States Diabetes Population (2011 – 2022)
• United States Insulin Users (2011 – 2022)
• United States Insulin Pen Users (2011 – 2022)
• United States Reusable (Cartridge) Insulin Pen Users (2011 – 2022)
• United States Prefilled (Disposable) Insulin Pen Users (2011 – 2022)
• United States Insulin Pen Market (2011 – 2022)
• United States Reusable (Cartridge) Insulin Pen Market (2011 – 2022)
• United States Prefilled (Disposable) Insulin Pen Market (2011 – 2022)
• United States Insulin Pen Market: Reimbursement & Regulation System
• Key Companies Analysis
• Key Drivers and Inhibitors of the United States Insulin Pen Market

Key Companies Covered in the Report are as follows:

• Novo Nordisk
• Eli Lilly
• Sanofi
• Owen Mumford

Read More

Table of Contents

1. Executive Summary

2. United States Diabetes Population & Insulin Users Analysis (2011 – 2022)
2.1 Overall Diabetes Population
2.2 Insulin Users

3. United States – Insulin Pen Users Trend & Analysis (2011 – 2022)
3.1 Insulin Pen Users & Forecast
3.1.1 Reusable (Cartridge) Insulin Pen Users
3.1.2 Prefilled (Disposable) Insulin Pen Users
3.2 Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Users Share

4. United States – Insulin Pen Market Trend & Analysis (2011 – 2022)
4.1 Insulin Pen Market & Forecast
4.1.1 Reusable (Cartridge) Insulin Pen Market
4.1.2 Prefilled (Disposable) Insulin Pen Market
4.2 Insulin Pen Segment – (Reusable & Prefilled Insulin Pen) Market Share

5. Key Drivers and Inhibitors of the United States Insulin Pen Market
5.1 Market Drivers
5.2 Inhibitors

6. United States Insulin Pen Market: Reimbursement & Regulation System
6.1 Reimbursement System
6.2 Regulation System

7. Key Companies Analysis
7.1 Novo Nordisk
7.1.1 Business Overview
7.1.2 Insulin Pen – Products Portfolio
7.1.3 Insulin Pen – Latest Development & Trends
7.2 Eli Lilly
7.2.1 Business Overview
7.2.2 Insulin Pen – Products Portfolio
7.2.3 Insulin Pen – Latest Development & Trends
7.3 Sanofi
7.3.1 Business Overview
7.3.2 Insulin Pen – Products Portfolio
7.4 Owen Mumford
7.4.1 Business Overview
7.4.2 Insulin Pen – Products Portfolio

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$1000
This license allows only one user to access the PDF.

Multi User

Electronic (PDF)
$1500
This license allows multiple user to access the PDF.

Corporate User

Electronic (PDF)
$1500
This license allows all the corporate employees to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Seventh Sense AI

RELATED REPORTS

Global Diabetic Foot Ulcer Treatment Market Size Status and Forecast 2021 2027
Global Diabetic Foot Ulcer Treatment Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-25O4196
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Insulin Infusion Pumps Market Research Report 2021
Global Insulin Infusion Pumps Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-3M4699
Thu Feb 04 00:00:00 UTC 2021

Add to Cart

Global Blood Glucose Testing Devices Market Research Report 2021
Global Blood Glucose Testing Devices Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-13Q4387
Mon Feb 01 00:00:00 UTC 2021

Add to Cart

Global Continuous Blood Glucose Monitoring Market Research Report 2021
Global Continuous Blood Glucose Monitoring Market Research Report 2021

120 Pages
Type: Report
Code: QYRE-Auto-31L4092
Mon Feb 01 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0